OncoGenex Announces that the Spruce Clinical Trial Evaluating OGX-427 is Now Open for Enrollment

barbara.lempert OncoGenex Announces that the Spruce™ Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer is Now ...

Nuvo Research announces 2013 second quarter results

barbara.lempert MISSISSAUGA, ON, July 31, 2013 /CNW/ – Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the ...

Sagent Pharmaceuticals Announces the Reintroduction of Amiodarone HCl Injection

barbara.lempert SCHAUMBURG, Ill., Aug. 5, 2013 (GLOBE NEWSWIRE) — Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the reintroduction of Amiodarone HCl Injection, an ...

Lilly Announces Deal to Train Minority Clinical Trial Investigators

mia.burns Lilly, Roswell Park Cancer Institute Partner to Train Minority Clinical Trial Investigators First-of-its-kind program aims to help improve diversity in clinical trials INDIANAPOLIS ...

Advanced Clinical Announces Cheryle Evans as New Vice President, Clinical Operations

barbara.lempert Deerfield, IL (August 1, 2013) — Advanced Clinical, a leading provider of clinical research solutions, today announced the addition of Cheryle Evans, RN, ...

Chelsea Therapeutics Announces Update to Northera (Droxidopa) NDA Filing

barbara.lempert CHARLOTTE, N.C., July 29, 2013 (GLOBE NEWSWIRE) — Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the U.S. Food and Drug Administration ...

Naurex Announces Issuance of New Patent for Novel Antidepressant Glyx-13

barbara.lempert —Extends Patent Life to 2030 for Novel Agent that Demonstrated Rapid Onset, Robust Efficacy and Good Safety in a Phase II Trial—   EVANSTON, IL – July 30, ...

Sorin Group Announces FDA 510(k) Clearance For The New Sorin Connect Perfusion Charting System

barbara.lempert Milan, July 30, 2013 – Sorin Group, (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced today the ...

Sanofi Pasteur Announces Shipment of First Lots of 2013-2014 Seasonal Influenza Vaccine in U.S.

barbara.lempert – Largest supplier of influenza vaccine in U.S., first to ship, will distribute more than 60 million doses of flu vaccines for fall immunization campaigns – ...

Sudler & Hennessey Announces Promotions and New Hires

barbara.lempert New York, July 23, 2013–– Sudler & Hennessey, a leading global healthcare  communication agency, is pleased to announce key promotions and new hires ...

Cadient Group Announces New Release of its Insights and Analytics Platform Reveal

mia.burns Philadelphia-based integrated marketing agency introduces its next generation socialized analytics and insights platform to accelerate collaborative decision making KING ...

GE Healthcare Announces CE Marking for Its Breast Tomosynthesis Solution, SenoClaire

barbara.lempert BUC, France–(BUSINESS WIRE)–GE Healthcare (NYSE: GE), hailed a new era for breast imaging today as it announced CE marking for SenoClaire*, GE’s new generation ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS